Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

Unveil the Secret of the Bacteria and Phage Arms Race. - Abstract - Europe PMC

Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

Genomic characterization of four novel bacteriophages infecting the clinical pathogen Klebsiella pneumoniae

A Jumbo Formation in the Viral Game Plan

Jumbophage infection is inhibited by the type III CRISPR-Cas system. A.

Identification of the bacteriophage nucleus protein interaction network

The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx

IJMS, Free Full-Text

Subcellular organization of viral particles during maturation of nucleus-forming jumbo phage

Viruses, Free Full-Text

The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx

Type III CRISPR-Cas Immunity: Major Differences Brushed Aside: Trends in Microbiology

Jumbo phage PCH45 evades type I, but not type III, CRISPR–Cas

Intracellular Organization by Jumbo Bacteriophages

The Rcs stress response inversely controls surface and CRISPR–Cas adaptive immunity to discriminate plasmids and phages